Allergen Immunotherapy management during vaccinations: An international survey.
Simonetta Masieri,Claus Bachert,Claus Bachert,Claus Bachert,Pedro Ojeda,Chang-Keun Kim,Cavaliere Carlo,Ciprandi Giorgio +7 more
TLDR
In this paper, an international survey has been performed involving a panel of experts who responded to a series of questions, also concerning the COVID-19 impact on allergen immunotherapy and vaccinations.About:
This article is published in World Allergy Organization Journal.The article was published on 2021-11-01 and is currently open access. It has received 4 citations till now. The article focuses on the topics: Allergen immunotherapy.read more
Citations
More filters
Journal ArticleDOI
Real‐life data on inactivated COVID‐19 vaccination in patients with subcutaneous allergen immunotherapy
Ying Yang Xu,Kai Guan +1 more
TL;DR: The safety of simultaneous receipt of COVID‐19 vaccination and SCIT was explored and the findings for the patients were similar to the results of an international survey in the allergy community.
Journal ArticleDOI
Comparing available treatments for pollen-induced allergic rhinitis in children
TL;DR: In this article , the authors discuss and compare the old and new therapeutic strategies for Pollen-induced allergic rhinitis (PIAR) in children, and compare them with new AIT formulations.
Journal ArticleDOI
Influenza and Other Prophylactic Vaccination Coverage in Polish Adult Patients Undergoing Allergen Immunotherapy—A Survey Study among Patients and Physicians
Ewa Czerwińska,Marita Nittner-Marszalska,J. Zaryczański,Grzegorz Gąszczyk,Agnieszka Mastalerz-Migas,Leszek Szenborn +5 more
TL;DR: Investigation of influenza vaccine and other selected prophylactic vaccines coverage in patients treated with AIT and the attitude of physicians towards vaccinations in this group of patients found prophyllactic vaccine coverage is not satisfactory among Polish adult patients undergoing AIT.
References
More filters
Journal ArticleDOI
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.
Aleena Banerji,Paige G. Wickner,Rebecca R. Saff,Cosby A. Stone,Lacey B. Robinson,Aidan A. Long,Anna R. Wolfson,Paul D. Williams,David A. Khan,Elizabeth J. Phillips,Kimberly G. Blumenthal +10 more
TL;DR: The U.S. Food and Drug Administration (FDA) has recently issued an Emergency Use Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines from Pfizer-BioNTech and Moderna.
Journal ArticleDOI
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.
Marcus Shaker,Marcus Shaker,John Oppenheimer,Mitchell H. Grayson,David R. Stukus,Nicholas Hartog,Elena W Y Hsieh,Nicholas L. Rider,Cullen M. Dutmer,Timothy K. Vander Leek,Harold Kim,Edmond S. Chan,Doug Mack,Anne K. Ellis,David M. Lang,Jay A. Lieberman,David Fleischer,David B.K. Golden,Dana Wallace,Jay M. Portnoy,Giselle Mosnaim,Matthew Greenhawt +21 more
TL;DR: An expert panel consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist/immunologist is forced to reduce services or makes the decision on his or her own to do so.
Journal ArticleDOI
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.
Ludger Klimek,Marek Jutel,Cezmi A. Akdis,Jean Bousquet,Mübeccel Akdis,Claus Bachert,Ioana Agache,I. J. Ansotegui,Anna Bedbrook,Sinthia Bosnic-Anticevich,Giorgio Walter Canonica,Tomas Chivato,Alvaro A. Cruz,Wiencyslawa Czarlewski,Stefano Del Giacco,Hui Du,João Fonseca,Ya-dong Gao,Tari Haahtela,Karin Hoffmann-Sommergruber,J. C. Ivancevich,N. Khaltaev,Edward F Knol,Piotr Kuna,D. Larenas-Linnemann,Erik Melén,Joaquim Mullol,Joaquim Mullol,Robert M. Naclerio,Ken Ohta,Yoshitaka Okamoto,Liam O'Mahony,Gabrielle L. Onorato,Nikos G Papadopoulos,Ruby Pawankar,Oliver Pfaar,Bolesław Samoliński,Jürgen Schwarze,Sanna Toppila-Salmi,Mohamed H. Shamji,Maria Teresa Ventura,Maria Teresa Ventura,Arunas Valiulis,Arzu Yorgancioglu,Arzu Yorgancioglu,P. M. Matricardi,Torsten Zuberbier +46 more
TL;DR: Allergen‐specific immunotherapy (AIT) is one of the most important treatment options for IgE‐mediated allergies and is based on immunological effects on the diseased patient.
Journal ArticleDOI
Allergy to COVID-19 vaccines: A current update.
TL;DR: In this paper, the authors provide an updated revision of the most current data regarding the anaphylactic reactions described for BNT162b2 vaccine, mRNA-1273 vaccine, and AZD1222 vaccine.
Journal ArticleDOI
Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism
TL;DR: In this article, the authors outline the hypotheses on the mechanisms behind the very rare thrombotic thromboembolic reactions reported after the COVID-19 vaccination, along with currently existing evidence and future research prospects.